Skip to main content
Top
Published in:

01-12-2025 | Review

Sleep and Neurodegeneration: Examining Potential Physiological Mechanisms

Authors: Brice V. McConnell, Yulin Deng, Brendan P. Lucey

Published in: Current Sleep Medicine Reports | Issue 1/2025

Login to get access

Abstract

Purpose of the Review

The purpose of this review is to provide an overview of potential mechanisms mediating the bi-directional relationship between sleep and neurodegenerative diseases such as Alzheimer’s disease. We provide updates on previously proposed mechanisms and identify new mechanisms particularly concerning how sleep disturbances affect memory-related neural circuits.

Recent Findings

In this review, we focus on the multiple mechanisms that potentially mediate the relationship between sleep and Alzheimer’s disease. We present updates for previously hypothesized mechanisms such as sleep-related changes in production/release and clearance of amyloid-β and tau proteins as well as more recently proposed mechanisms relating to tau phosphorylation, the orexin system, astrocytes, and microglia. We also highlight how disruptions in sleep EEG oscillations that underlie memory-related neural circuits, such as slow wave activity, theta bursts, sleep spindles, and gamma ripples, change in Alzheimer’s disease.

Summary

Disturbed sleep increases Alzheimer’s disease risk via multiple potential mechanisms that suggest multiple targets to test approved and effective treatments of sleep disorders to prevent or delay Alzheimer’s disease.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Sleep and Neurodegeneration: Examining Potential Physiological Mechanisms
Authors
Brice V. McConnell
Yulin Deng
Brendan P. Lucey
Publication date
01-12-2025
Publisher
Springer International Publishing
Published in
Current Sleep Medicine Reports / Issue 1/2025
Electronic ISSN: 2198-6401
DOI
https://doi.org/10.1007/s40675-024-00316-6

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest

How can you integrate PET into your practice? (Link opens in a new window)

1.5 AMA PRA Category 1 Credit(s)™

PET imaging is playing an increasingly critical role in managing AD. Our expert-led program will empower you with practical strategies and real-world case studies to effectively integrate it into clinical practice.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest